Current testing for most diagnostic applications is slow, inefficient, and expensive, which contributes to massive under-diagnosis, under treatment, Read More
Point-of-care diagnostic company Senzo raises $1.9M
Current testing for most diagnostic applications is slow, inefficient, and expensive, which contributes to massive under-diagnosis, under treatment, Read More